-
Viperin Disrupts Coronavirus RTC Assembly via nsp8
2026-09-02
A 2026 study identifies a second anti-coronavirus mechanism for viperin beyond ddhCTP-mediated RNA chain termination. Using porcine deltacoronavirus, the authors show that viperin binds nsp8, disrupts replication-transcription complex assembly, and reduces viral RNA-dependent RNA polymerase activity, suggesting a conserved target for antiviral drug development.
-
Bovine Liver Organoids for Dairy Cow Fatty Liver
2026-09-01
Lei et al. developed a bovine liver organoid platform from calf-derived adult stem cells and used fatty-acid loading to model lipid accumulation relevant to dairy-cow fatty liver. The study also demonstrates that the organoids can support comparative testing of natural compounds and atorvastatin, offering a reduction-oriented complement to live-animal experiments.
-
Brain-to-Spinal Control of Opioid Mechanical Hypersensitivit
2026-09-01
A 2024 Neuron study identifies a lateral parabrachial–hypothalamic–spinal pathway that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The work separates mechanical opioid side effects from better-established thermal mechanisms and provides a circuit framework for targeted pain mechanism research.
-
Elobixibat Hydrate: From IBAT to Assay Logic
2026-08-31
Elobixibat hydrate is an ileal bile acid transporter inhibitor whose local intestinal action links bile acid flux with motility and metabolic signaling. This article presents a phenotype-to-pathway framework for designing better IBAT experiments while separating target engagement, compartment effects, and clinical translation.
-
Polybrene: From Viral Delivery to Translational Design
2026-08-31
Polybrene, also known as Hexadimethrine Bromide, is more than a routine transduction additive: it is a controllable variable in the chain linking molecular perturbation to interpretable cell biology. This thought-leadership perspective connects its delivery mechanism with emerging FBXO22 targeted protein degradation research and outlines a disciplined path from viral gene delivery to translationally useful evidence.
-
HLY78: Precision Control of Wnt/β-Catenin Signaling
2026-08-30
HLY78 is a ligand-dependent Wnt/β-catenin pathway modulator that acts through the Axin DIX domain to enhance Axin-LRP6 engagement. This article connects its mechanistic profile with zebrafish developmental evidence and the emerging role of Wnt signaling in oral submucous fibrosis, while outlining a disciplined strategy for pathway validation, assay controls, and translational interpretation.
-
EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Delivery
2026-08-29
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA reporter that separates delivery tracking from functional EGFP expression. Its Cap1 structure and modified uridine chemistry support research on mRNA delivery and translation efficiency assay workflows, while product specifications define handling, concentration, and storage requirements.
-
Firefly Luciferase mRNA Workflow Guide
2026-08-28
Build sensitive reporter assays with a Cap1-capped, 5-moUTP-modified transcript engineered for sustained firefly luciferase expression. This guide connects practical mRNA handling and transfection design with PEG-lipid choices that can determine LNP performance from cell culture to animal imaging.
-
miR-196a Drives EAC Through the MYC/TERT/NFκB Axis
2026-08-28
García-Castillo and colleagues show that miR-196a is not only a marker of esophageal adenocarcinoma progression but also a functional driver of aggressive behavior through a MYC/TERT/NFκB signaling axis. The study combines miRNA perturbation, EMT and motility assays, pathway inhibition, telomerase measurements, and Barrett’s esophagus tissue analysis to connect molecular mechanism with disease progression.
-
Super-Enhancer RNA Drives NPC Metastasis
2026-08-27
A 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a regulatory driver of nasopharyngeal carcinoma metastasis. By integrating transcriptomic, nascent-transcription, chromatin, perturbation, and tissue-validation approaches, the authors connect seRNA-NPCm to an NPM1/c-Myc/NDRG1 regulatory axis.
-
H 89 2HCl for cAMP/PKA Assay Design
2026-08-27
Use H 89 2HCl to separate downstream PKA-dependent phosphorylation from upstream cAMP production in neuronal and mechanotransduction assays. This practical guide connects dose-controlled kinase inhibition with trigeminal neuralgia workflows involving CGRP, substance P, Piezo2, Ca²⁺ signaling, and mechanical allodynia.
-
Mitochondrial TERC-53 Signaling in Senescence
2026-08-26
The reference study identifies mitochondrion-processed TERC-53 as a non-coding RNA signal that links mitochondrial status to cellular senescence and age-associated cognitive decline without changing telomerase activity. Its experimental design separates TERC-53 signaling from canonical telomere maintenance and provides a framework for studying specific mitochondrial retrograde communication.
-
KPT-330 (Selinexor): Assay Q&A
2026-08-26
This scenario-based guide explains how KPT-330 (Selinexor), selective CRM1 inhibitor, supports cell viability, apoptosis, and combination studies. It covers SKU B1464 handling, assay interpretation, and evidence from recent XPO1-inhibition research.
-
EZ Cap™ Cas9 mRNA for Neurobiology
2026-08-25
EZ Cap™ Cas9 mRNA (5-moUTP) supports transient CRISPR-Cas9 genome editing in neurobiology. This guide translates a zebrafish Fyn–Stat3 study into practical assay design, controls, and interpretation strategies.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-25
Zeng and colleagues developed chemically modified p21 mRNA-loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. Their preclinical data show bladder-restricted expression, restoration of tumor-suppressive cell-cycle control, and reduced tumor growth, while also identifying delivery, formulation, and translational questions for future studies.